Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Smaller, shallow brain folds in the posteromedial cortex show greater thinning with age and Alzheimer’s disease, and their ...

The lead author of a new study believes "our brain's hidden sugar code could unlock powerful tools for combating dementia" ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

A multi-strain probiotic blend shows promise for protecting brain function by reducing gut-triggered inflammation linked to ...

Participants who chose not to learn their results said it would place a burden on themselves and their family members. As ...

Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

Scientists identify stress granules as the potential root cause of Alzheimer's disease. This new understanding may ...